Raiteri M, Maura G, Barzizza A
Istituto di Farmacologia e Farmacognosia, Università degli Studi di Genova, Italy.
J Pharmacol Exp Ther. 1991 Jun;257(3):1184-8.
In rat cerebellar slices, depolarization with 35 mM KCl caused increase of cyclic GMP (cGMP) production. This increase was Ca(++)-dependent, similar to the K(+)-evoked release of glutamate and aspartate in the same preparation. The K(+)-induced cGMP formation was inhibited in a concentration-dependent manner by D-(-)-2-amino-5-phosphonopentanoic acid (maximal inhibition 60-70%; IC50 = 0.019 microM) indicating the involvement of N-methyl-D-aspartate receptors probably activated by excitatory amino acids (EAAs) released by K(+)-depolarization. The cGMP production evoked by high-K+ was also potently inhibited by 5-hydroxytryptamine (5-HT; IC50 = 0.42 nM) or by 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT; IC50 = 1 nM). Methiothepin prevented the action of both 5-HT and 8-OH-DPAT. These data suggest the involvement of 5-HT1-like receptors. When added alone to the depolarized slices, methiothepin (0.03-3 microM) produced a concentration-dependent increase of cGMP suggesting that the 5-HT1-like receptors may be physiologically activated by the endogenous transmitter. Endogenous 5-HT released by (+)-fenfluramine (1 microM) or remaining in the biophase due to reuptake inhibition by citalopram (1 microM) caused reduction of cGMP compatible with a close apposition between 5-HT and EAA terminals. It can be concluded that activation (either direct or indirect) or blockade of presynaptic 5-HT1-like receptors previously found to be sited on EAA terminals in rat cerebellum where they mediate decrease of EAA release may profoundly affect the postsynaptic response elicited by EAA receptors coupled to guanylate cyclase.
在大鼠小脑切片中,用35 mM氯化钾进行去极化会导致环磷酸鸟苷(cGMP)生成增加。这种增加依赖于钙离子(Ca(++)),类似于同一样品中钾离子诱发的谷氨酸和天冬氨酸的释放。D-(-)-2-氨基-5-磷酸戊酸以浓度依赖的方式抑制钾离子诱导的cGMP形成(最大抑制率为60 - 70%;IC50 = 0.019 microM),这表明N-甲基-D-天冬氨酸受体可能参与其中,可能是被钾离子去极化释放的兴奋性氨基酸(EAAs)激活。高钾诱发的cGMP生成也被5-羟色胺(5-HT;IC50 = 0.42 nM)或8-羟基-2-(二-N-丙基氨基)四氢萘(8-OH-DPAT;IC50 = 1 nM)强烈抑制。甲硫哒嗪可阻止5-HT和8-OH-DPAT的作用。这些数据表明5-HT1样受体参与其中。当单独添加到去极化切片中时,甲硫哒嗪(0.03 - 3 microM)会导致cGMP呈浓度依赖性增加,这表明5-HT1样受体可能被内源性递质生理性激活。由(+)-芬氟拉明(1 microM)释放或由于西酞普兰(1 microM)对再摄取的抑制而留在生物相中内源性5-HT导致cGMP减少,这与5-HT和EAA终末紧密相邻相一致。可以得出结论,先前发现位于大鼠小脑EAA终末的突触前5-HT1样受体的激活(直接或间接)或阻断,在那里它们介导EAA释放减少,可能会深刻影响与鸟苷酸环化酶偶联的EAA受体引发的突触后反应。